The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic Dermatitis
The Child ECT and Caregiver ADCT were developed and qualitatively validated for assessing AD control in patients aged 6 months to 11 years and may offer simple ways to assess disease control and optimize treatment decisions. Video Abstract.
Authors
- Sheri Fehnel (ORCID: https://orcid.org/0000-0001-8568-0102)
- Eric L. Simpson (ORCID: https://orcid.org/0000-0003-0853-0252)
- Chien‐Chia Chuang (ORCID: https://orcid.org/0000-0002-0895-4998)
- Jennifer Dine (ORCID: https://orcid.org/0000-0002-2121-9752)
- David M. Pariser (ORCID: https://orcid.org/0000-0003-2250-9361)
- T. Michelle Brown (ORCID: https://orcid.org/0000-0002-4580-805X)
- Zhixiao Wang (ORCID: https://orcid.org/0000-0003-1928-3103)
Institutions
- Eastern Virginia Medical School (US)
- Oregon Health & Science University (US)
- RTI International (US)
- Regeneron (United States) (US)
- Sanofi (France) (FR)
- Virginia Clinical Research (US)
- Sanofi (United States) (US)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1007/s13555-024-01289-8
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Sanofi
- Regeneron Pharmaceuticals